It is hypothesized that the dual nature of RBM47’s impact on tumorigenesis may be influenced by factors such as tumor heterogeneity, pathological subtypes, or molecular mechanisms, leading to disease-specific outcomes. This evidence concerns the gene RBM47 and neoplasm.